Retinitis pigmentosa and nanophthalmos in a patient with attenuated Hunter’s syndrome

Purpose To describe a case of retinitis pigmentosa and nanophthalmos in a patient with attenuated Hunter’s syndrome. Methods Fundus photography, total field electroretinogram, ultrasound, computerized visual field examination, biochemical examination and genetic testing were obtained. Results The fu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Documenta ophthalmologica 2023-06, Vol.146 (3), p.273-279
Hauptverfasser: dos Santos Martins, Thiago Gonçalves, de Azevedo Costa, Ana Luiza Fontes, Pimentel, Sérgio Luís Gianotti, Oyamada, Maria Kiyoko, Finzi, Simone
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To describe a case of retinitis pigmentosa and nanophthalmos in a patient with attenuated Hunter’s syndrome. Methods Fundus photography, total field electroretinogram, ultrasound, computerized visual field examination, biochemical examination and genetic testing were obtained. Results The fundus exam showed diffuse arteriolar attenuation, optic disc with regular contours, and pigment agglomerates like "bone spicules" in the middle periphery . Ultrasound examination revealed scleral thickening and short axial diameter in both eyes. The total field electroretinogram exam showed a subnormal result with greater impairment of the scotopic phase of the exam. Computerized visual field examination demonstrated a diffuse reduction in retinal sensitivity in the periphery. Biochemical examination showed increased urine glycosaminoglycan excretion and iduronate-2-sulphatase activity (IDS) deficiency in leukocytes, confirming the type II mucopolysaccharidosis. Molecular analysis revealed a novel missense mutation (p.A77D) in the IDS gene. Conclusion The case report is about a patient presented an attenuated form of the syndrome, with no cognitive impairment. Ophthalmologic follow-up is still an important part of multidisciplinary treatment for Hunter’s syndrome.
ISSN:0012-4486
1573-2622
DOI:10.1007/s10633-023-09924-z